Fundamental differences during Gram-positive versus Gram-negative sepsis become apparent during bacterial challenge of D-galactosamine-treated mice
- 1 June 1997
- journal article
- Published by SAGE Publications in Innate Immunity
- Vol. 4 (3) , 173-181
- https://doi.org/10.1177/096805199700400302
Abstract
Gram-negative and Gram-positive bacteria have been compared with respect to lethal effects when each is administered to normal and D-galactosamine-sensitized mice, both with and without concomitant dexamethasone treatment. In the case of Escherichia coli, the extent of sensitization by D-galactosamine treatment (10,000-fold) and the relative magnitude of the corresponding protection with dexamethasone (150-fold) are both consistent with an expected significant role of LPS in production of TNFα that then mediates lethal toxicity. With Staphylococcus aureus, however, marginal sensitization by D-galactosamine (5-fold) and a corresponding lack of dexamethasone protection indicate a reduced role for TNFα as a lethal mediator. In vitro comparisons of TNFα release from E. coli and S. aureus stimulated peritoneal macrophages (100-fold difference) add further support to this conclusion. Endotoxin hypo-responsive mice (C3H/HeJ) infected with E. coli are not protected by dexamethasone. Each of these comparisons indicate that the contribution of TNFα to the pathophysiological manifestations of experimental sepsis may vary substantially even among extracellular bacteria and, correspondingly, that differential dexamethasone protection may serve a discriminatory function for the potential involvement of this cytokine.Keywords
This publication has 43 references indexed in Scilit:
- CorrespondenceInnate Immunity, 1997
- Review: Evidence against the hypothesis that antibodies to the inner core of lipopolysaccharides in antisera raised by immunization with enterobacterial deep-rough mutants confer broad-spectrum protection during Gram-negative bacterial sepsisInnate Immunity, 1997
- Potentia Hazards of Combination Immunotherapy in the Treatment of Experimental Septic ShockThe Journal of Infectious Diseases, 1996
- The protein kinase C activator PMA modulates LPS lethality in normal mice and protects against LPS lethality in D-galactosamine-sensitized miceInnate Immunity, 1996
- Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future directionInnate Immunity, 1994
- Minireview: Therapeutic intervention in sepsis with antibody to endotoxin: is there a future?Innate Immunity, 1994
- Detrimental effects of high-dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shockCritical Care Medicine, 1993
- Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal SubjectsNew England Journal of Medicine, 1990
- Survey of purported virulence factors ofEscherichia coli isolated from blood, urine and stoolEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987